Ovarian failure is a typical feature in Turner's syndrome. Therefore, hormo
ne replacement therapy (HRT) is necessary to achieve the development of nor
mal female sexual characteristics and to prevent cardiovascular complicatio
ns and osteoporosis. Spontaneous puberty occurs in 5-10% of women with Turn
er's syndrome, and 2-5% of them become pregnant spontaneously. Sexually act
ive young women with Turner's syndrome need contraception. It can be admini
stered as contraceptive pills, which also serve as HRT. Oocyte donation is
now a treatment option for infertility of these women. Excellent results ha
ve been obtained with 46% of embryo transfers resulting in pregnancy. The p
regnancies carry high risks and have to be followed up carefully. The child
ren born following oocyte donation have no additional risks. Risks can be r
educed by transferring only one embryo at a time to the uterus, thus avoidi
ng twin pregnancies. Ovarian tissue from young girls with Turner's syndrome
could be cryopreserved for infertility treatment in the future, but the op
timal age of ovarian biopsy has to be studied, and methods of replantation
and maturation of oocytes in vitro have still to be developed. Fertility co
unselling has become important in the treatment of girls with Turner's synd
rome.